Loading Events

« All Events

  • This event has passed.

LifeSciences BC Blakes Breakfast Speaking Event on Digital Health

February 16 @ 7:30 AM - 9:30 AM

This Breakfast Speaking Series is proudly presented by:


LifeSciences BC is pleased to announce our January Blakes Breakfast Speaking Event on Digital Health for Thursday, February 16, 2017.

– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –

The Blakes Breakfast Speaking Series is our longest-standing event series and one of our most popular. Held four times a year, these breakfasts include presentations by local, national and multinational life science companies and typically attract a cross-section of approximately 40 of our life sciences community members. The Breakfast Speaking Series is proudly presented by Blake, Cassels & Graydon LLP.




Company Profiles:

  • GenomeDx develops and commercializes transformative genomic tests that clarify decisions about the course of treatment for patients with urologic cancers. Their first test, Deciphera, provides a direct measure of the true biological risk of prostate cancer metastasis in patients following radical prostatectomy. This measure is specific to metastasis and is independent of PSA and the presence of adverse features.

GenomeDx curates the world’s most comprehensive genomic activity database on metastatic prostate cancer and couples it to cloud-based informatics to analyze millions of data points from a patient’s tumor. Collaboration with experts at world-renowned medical institutions enables the effective use of this genome-wide approach to discover, develop and rapidly deploy best-in-class genomic activity tests.

  • HealthTech Connex Inc. is dedicated towards bringing advanced, innovative health care technologies to care givers and patients today.

Located in the Health & Technology District on Innovation Boulevard, HealthTech Connex Inc. focuses on technology-based innovations for rapid impact in health improvements and outcomes.

With a focus on global health priorities, our mandate is to connect advanced R&D to product breakthroughs with the largest possible societal benefit. With brain vitality as a premier focus, HealthTech Connex Inc. provides translational neuroscience innovations to care and community sectors world wide.

Our team is comprised of health, science and business leaders with extensive experience in healthcare advances.

HealthTech Connex Inc. is proud to contribute to Innovation Boulevard’s vision to deliver health technology solutions that touch people’s lives.

  • ViewsIQ is a healthcare technology company, digitizing patient samples microscopically to disrupt the pathology practice – the last remaining medical imaging field to go digital.

ViewsIQ’s Panoptiq system is the first software-based approach to digital imaging that allows seamless integration into a Pathologist’s clinical workflow. With Panoptiq, the cost barrier to digital imaging has been removed, permitting clinicians to offer expert diagnostic care to patients virtually anywhere in the world.

Speaker Profiles: 

wellman-headshot Hugh Wellman, Director, BD, Licensing and IP, GenomeDx

Hugh Wellman is Director, BD, Licensing and IP at GenomeDx and has been with the company since 2013.  His responsibilities include, business development, licensing with both academic and commercial partners and management of the IP portfolio.  He has spent the last 10 years working with venture capital funded biotech companies.  Before GenomeDx he worked at Sirius Genomics, a commercially focused, pharmacogenomics company.  While working with Sirius he built a SNP selection pipeline, managed 3 major genotyping initiatives and was the scientific lead in the largest pharmacogenomic trial ever completed in sepsis.  Additionally he led extensive association analysis and was involved in the development of 9 resulting inventions.  Wellman has played a key role at both companies in establishing broad strategic partnerships and licensing arrangements with pharma/biotech companies and academic institutions for the purpose of biomarker discovery and commercialization.  Hugh received his undergrad and MSc in Genetics at the University of British Columbia.

Dr. Ryan D'Arcy Dr. Ryan D’Arcy, Co-founder &senior scientist/entrepreneur for Health Tech Connex

Trained in neuroscience and medical imaging, Dr. D’Arcy holds a BC Leadership Chair in Medical Technology and is full Professor at Simon Fraser University.
He also serves as Head of Health Sciences and Innovation at Fraser Health’s Surrey Memorial Hospital and is widely recognized for founding Innovation Boulevard. Dr. D’Arcy received a B.Sc. (with distinction) from University of Victoria along with both M.Sc. and Ph.D. degrees in neuroscience from Dalhousie University.

He did post-doctoral training in medical imaging at the National Research Council’s Institute for Biodiagnostics, and spent over a decade leading the development of Atlantic Canada’s biomedical imaging cluster. He has extensive experience in translational neuro-imaging, has been the driving force in taking several biotechnology products to market.

Herman Lo Profile Picture Herman Lo, CEO, ViewsIQ Inc.

Herman Lo leads the management team as the primary founder of ViewsIQ. He founded the company as an inspiration from his Master’s research in Human Factors and Biomedical Engineering at University of Toronto. He has over eleven years of experience in building imaging software and seven years of experience in entrepreneurship. He has raised over CDN$3M in funding for ViewsIQ and responsible for initial Panoptiq product sales of CDN$1.2M since inception.

In addition to being the driving force behind all R&D initiatives, Herman now focuses on forging customer relationships and aligning the sales, marketing and technical teams on the management team’s corporate strategy to achieve sustainable growth in revenue and shareholder value.


Event Details:

Date: Thursday, February 16, 2017

 7:30 – 8:00 AM– Registration and Hot Breakfast
 8:00 – 9:00 AM – Presentations
 9:00 – 9:30 AM – Networking Opportunity

Location: Terminal City Club – 837 West Hastings Street, Vancouver



*No refunds given within 72 hours of event start.


For more information, please contact:

Irma Zukic
Administrative Coordinator
LifeSciences BC
Tel: 604-669-9909 ext. 1 │ Email: izukic@lifesciencesbc.ca


February 16
7:30 AM - 9:30 AM
Event Category:


LifeSciences BC


Terminal City Club
837 West Hastings Street
+ Google Map